BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34286547)

  • 21. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
    Géczi L; Gomez F; Bak M; Bodrogi I
    J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilateral germ-cell testicular cancer - long-term experience.
    Ondruš D; Ondrušová M; Št'astná V
    Klin Onkol; 2013; 26(6):421-4. PubMed ID: 24320591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older.
    Feldman DR; Voss MH; Jacobsen EP; Jia X; Suarez JA; Turkula S; Sheinfeld J; Bosl GJ; Motzer RJ; Patil S
    Cancer; 2013 Jul; 119(14):2574-81. PubMed ID: 23606402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current management of stage I testicular germ cell tumors in a French cancer institute. A practice analysis over the 10 past years.
    Chanal E; Bouleftour W; Guillot A; Rowinski E; Bernichon E; Tremeau L; Lardon R; Lacroix B; Lorin S; Delorme G; Perraud Y; Armand C; Levigne F; Vallard A; Langrand-Escure J; Fournel P; Benoite M; Vassal C
    Bull Cancer; 2019 Dec; 106(12):1086-1093. PubMed ID: 31582176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late relapse in stage I of nonseminomatous germ cell testicular cancer on surveillance.
    Ondrusova M; Suchansky M; Psota M; Zeleny T; Ondrus D
    Bratisl Lek Listy; 2018; 119(1):3-5. PubMed ID: 29405722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages.
    Kliesch S; Schmidt S; Wilborn D; Aigner C; Albrecht W; Bedke J; Beintker M; Beyersdorff D; Bokemeyer C; Busch J; Classen J; de Wit M; Dieckmann KP; Diemer T; Dieing A; Gockel M; Göckel-Beining B; Hakenberg OW; Heidenreich A; Heinzelbecker J; Herkommer K; Hermanns T; Kaufmann S; Kornmann M; Kotzerke J; Krege S; Kristiansen G; Lorch A; Müller AC; Oechsle K; Ohloff T; Oing C; Otto U; Pfister D; Pichler R; Recken H; Rick O; Rudolph Y; Ruf C; Schirren J; Schmelz H; Schmidberger H; Schrader M; Schweyer S; Seeling S; Souchon R; Winter C; Wittekind C; Zengerling F; Zermann DH; Zillmann R; Albers P
    Urol Int; 2021; 105(3-4):169-180. PubMed ID: 33412555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy analysis of three therapeutic modes on clinical stage Ia nonseminomatous germ cell testicular tumors].
    Dong P; Liu ZW; Li XD; Wu S; Li YH; Yao K; Qin ZK; Han H; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2013 Mar; 51(3):256-60. PubMed ID: 23859330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second malignancies in long-term testicular cancer survivors.
    Ondrus D; Ondrusova M; Friedova L
    Int Urol Nephrol; 2014 Apr; 46(4):749-56. PubMed ID: 24096370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel rapid access testicular cancer clinic: prospective evaluation after one year.
    Carey K; Davis NF; Elamin S; Ahern P; Brady CM; Sweeney P
    Ir J Med Sci; 2016 Feb; 185(1):215-8. PubMed ID: 25772124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital.
    Sarikaya S; Karsiyakali N; Kaya E; Topuz B; Ebiloglu T; Zor M
    Actas Urol Esp (Engl Ed); 2021; 45(1):30-38. PubMed ID: 33010987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.
    Funt SA; Patil S; Feldman DR; Motzer RJ; Bajorin DF; Sheinfeld J; Tickoo SK; Reuter VE; Bosl GJ
    J Clin Oncol; 2019 Sep; 37(26):2329-2337. PubMed ID: 31233353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference.
    Nicolai N; Biasoni D; Catanzaro MA; Colecchia M; Trama A;
    Eur J Surg Oncol; 2019 Jan; 45(1):60-66. PubMed ID: 29526370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Part I: testicular cancer--management of early disease.
    Jones RH; Vasey PA
    Lancet Oncol; 2003 Dec; 4(12):730-7. PubMed ID: 14662429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
    Considine S; Heaney R; Conroy R; Thornhill JA
    Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical profile, treatment and survival outcome of testicular tumors: a pakistani perspective.
    Bhatti AB; Ahmed I; Ghauri RK; Saeed Q; Mir K
    Asian Pac J Cancer Prev; 2014; 15(1):277-80. PubMed ID: 24528039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors.
    Hashimoto K; Fujimoto H; Kouno T; Koseki M; Yonemori K; Hirata T; Yunokawa M; Shimizu C; Katsumata N; Tamura K; Ando M; Takeuchi M; Nakanishi H; Komiyama M; Nakagawa T; Fujiwara Y
    Urol Oncol; 2012; 30(3):319-24. PubMed ID: 20471872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.
    Dieckmann KP; Albers P; Classen J; De Wit M; Pichlmeier U; Rick O; Müllerleile U; Kuczyk M
    J Urol; 2005 Mar; 173(3):824-9. PubMed ID: 15711278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of primary metastatic bone disease in germ cell tumors: results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study.
    Oing C; Oechsle K; Necchi A; Loriot Y; De Giorgi U; Fléchon A; Daugaard G; Fedyanin M; Faré E; Bokemeyer C
    Ann Oncol; 2017 Mar; 28(3):576-582. PubMed ID: 27993806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment and survival patterns for germ cell tumors among 13- to 24-year olds in Yorkshire, UK.
    Feltbower RG; Siller C; Woodward E; McKinney PA; Picton SV; Joffe J; Stark DP
    Pediatr Blood Cancer; 2011 Feb; 56(2):282-8. PubMed ID: 21157895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of testicular germ cell tumors relapse].
    Carbonnaux M; Vinceneux A; Peyrat P; Fléchon A
    Bull Cancer; 2020 Sep; 107(9):912-924. PubMed ID: 32653158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.